These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Absence of p21(CIP 1), p27(KIP 1) and p 57(KIP 2) methylation in MDS and AML. Brakensiek K; Länger F; Kreipe H; Lehmann U Leuk Res; 2005 Nov; 29(11):1357-60. PubMed ID: 15936816 [TBL] [Abstract][Full Text] [Related]
27. SOCS-3 is frequently silenced by hypermethylation and suppresses cell growth in human lung cancer. He B; You L; Uematsu K; Zang K; Xu Z; Lee AY; Costello JF; McCormick F; Jablons DM Proc Natl Acad Sci U S A; 2003 Nov; 100(24):14133-8. PubMed ID: 14617776 [TBL] [Abstract][Full Text] [Related]
28. Quantitative detection of methylated SOCS-1 , a tumor suppressor gene, by a modified protocol of quantitative real time methylation-specific PCR using SYBR green and its use in early gastric cancer detection. Chan MW; Chu ES; To KF; Leung WK Biotechnol Lett; 2004 Aug; 26(16):1289-93. PubMed ID: 15483389 [TBL] [Abstract][Full Text] [Related]
29. Thyrotropin induces SOCS-1 (suppressor of cytokine signaling-1) and SOCS-3 in FRTL-5 thyroid cells. Park ES; Kim H; Suh JM; Park SJ; Kwon OY; Kim YK; Ro HK; Cho BY; Chung J; Shong M Mol Endocrinol; 2000 Mar; 14(3):440-8. PubMed ID: 10707961 [TBL] [Abstract][Full Text] [Related]
30. SOCS1 and SHP1 hypermethylation in multiple myeloma: implications for epigenetic activation of the Jak/STAT pathway. Chim CS; Fung TK; Cheung WC; Liang R; Kwong YL Blood; 2004 Jun; 103(12):4630-5. PubMed ID: 14976049 [TBL] [Abstract][Full Text] [Related]
31. Aberrant p15 gene promoter methylation in therapy-related myelodysplastic syndrome and acute myeloid leukaemia: clinicopathological and karyotypic associations. Au WY; Fung A; Man C; Ma SK; Wan TS; Liang R; Kwong YL Br J Haematol; 2003 Mar; 120(6):1062-5. PubMed ID: 12648079 [TBL] [Abstract][Full Text] [Related]
32. Differential hypermethylation of SOCS genes in ovarian and breast carcinomas. Sutherland KD; Lindeman GJ; Choong DY; Wittlin S; Brentzell L; Phillips W; Campbell IG; Visvader JE Oncogene; 2004 Oct; 23(46):7726-33. PubMed ID: 15361843 [TBL] [Abstract][Full Text] [Related]
36. Inhibitory roles for SHP-1 and SOCS-3 following pituitary proopiomelanocortin induction by leukemia inhibitory factor. Bousquet C; Susini C; Melmed S J Clin Invest; 1999 Nov; 104(9):1277-85. PubMed ID: 10545526 [TBL] [Abstract][Full Text] [Related]
37. Suppressors of cytokine signalling (SOCS): putative modulators of cytokine bioactivity in health and disease. Diamond P; Doran P; Brady HR; McGinty A J Nephrol; 2000; 13(1):9-14. PubMed ID: 10720209 [TBL] [Abstract][Full Text] [Related]
38. SOCS-3 is involved in the downregulation of the acute insulin-like effects of growth hormone in rat adipocytes by inhibition of Jak2/IRS-1 signaling. Ridderstråle M; Amstrup J; Hilton DJ; Billestrup N; Tornqvist H Horm Metab Res; 2003 Mar; 35(3):169-77. PubMed ID: 12734778 [TBL] [Abstract][Full Text] [Related]
39. SOCS-1 suppresses TNF-alpha-induced apoptosis through the regulation of Jak activation. Kimura A; Naka T; Nagata S; Kawase I; Kishimoto T Int Immunol; 2004 Jul; 16(7):991-9. PubMed ID: 15173123 [TBL] [Abstract][Full Text] [Related]
40. Negative regulation of onconstatin M signaling by suppressor of cytokine signaling (SOCS-3). Magrangeas F; Boisteau O; Denis S; Jacques Y; Minvielle S Eur Cytokine Netw; 2001; 12(2):309-15. PubMed ID: 11399520 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]